Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 5 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors at 3 institutions in 1 country.
Ana M GonçalvesCICS-UBI-Health Sciences Research Centre, University of Beira Interior, 6201-506 Covilhã, Portugal.
Augusto Q PedroChemistry Department, CICECO-Aveiro Institute of Materials, University of Aveiro, Campus Universitário de Santiago, 3810-193 Aveiro, Portugal.
Diana M OliveiraCICS-UBI-Health Sciences Research Centre, University of Beira Interior, 6201-506 Covilhã, Portugal.
Adriana E OliveiraCICS-UBI-Health Sciences Research Centre, University of Beira Interior, 6201-506 Covilhã, Portugal.
Marino F A SantosAssociate Laboratory i4HB-Institute for Health and Bioeconomy, NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2819-516 Caparica, Portugal.ORCID 0000-0002-8205-1041
Márcia A S CorreiaAssociate Laboratory i4HB-Institute for Health and Bioeconomy, NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2819-516 Caparica, Portugal.
João A QueirozCICS-UBI-Health Sciences Research Centre, University of Beira Interior, 6201-506 Covilhã, Portugal.ORCID 0000-0002-3096-8325
Eugénia GallardoCICS-UBI-Health Sciences Research Centre, University of Beira Interior, 6201-506 Covilhã, Portugal.ORCID 0000-0002-1802-8998
Maria J RomãoAssociate Laboratory i4HB-Institute for Health and Bioeconomy, NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2819-516 Caparica, Portugal.ORCID 0000-0002-3004-0543
Luís A PassarinhaCICS-UBI-Health Sciences Research Centre, University of Beira Interior, 6201-506 Covilhã, Portugal.ORCID 0000-0001-6910-7576
University of Beira Interior · PTUniversidade Nova de Lisboa · PTUniversity of Aveiro · PT
Funding
COMPETE 2020-Programa Operacional Competitividade e Internacionalização IL2BioPro"-PTDC/BII-BBF/30840/2017European Regional Development Fund Centro-01-0145-FEDER-000019-C4-Centro de Competências em Cloud ComputingFundação para a Ciência e Tecnologia UIDB/00709/2020; UIDP/00709/2020; UIDB/50011/2020; UIDP/50011/2020;UIDB/04378/2020; UIDP/04378/2020; LA/P/0006/2020; LA/P/0140/2020; SFRH/BD/147519/2019; CEEC-IND/02599/2020; SFRH/BSAB/150376/2019
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Thermofluor-Based Optimization Strategy for the Stabilization of Recombinant Human Soluble Catechol- · full record | OpenQuestion